| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.049 | 0.2 |